No intervention
Otherno intervention
NCT Number: NCT03453827
To evaluate long-term intraocular lens (IOL) decentration and tilt in eyes with pseudoexfoliation syndrome (PES) following cataract surgery using Visante anterior segment OCT and iTrace Visual Function Analyzer.
Looking for future studies?
Notify Me18 year–125 year
All sexes
Observational
64 eyes following cataract surgery from 2009 to 2012 were included, 34 eyes had PES, 30 eyes did not show PES. A standard phacoemulsification procedure followed by IOL implantation was performed and patients were followed 4-6 years after surgery (mean=69 months). Best corrected visual acuity (BCVA), intraocular pressure (IOP) and capsulorhexis size were measured. IOL tilt and IOL decentration were evaluated using Visante Omni anterior segment OCT (Carl Zeiss Jena GmBH, Germany). The iTrace VFA (Visual Function Analyzer, Topcon Medical Systems, Inc.) was used to measure internal, corneal and total optical aberrations.
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
no intervention
Time frame: 4-6 years after cataract surgery
decentration of IOL is measured using Hoya iTrace
Time frame: 4-6 years after cataract surgery
tilt of implanted IOL is measured using Hoya iTace
Time frame: 4-6 years after cataract surgery
decentration of IOL is measured using Zeiss OCT
Time frame: 4-6 years after cataract surgery
tilt of implanted IOL is measured using Zeiss OCT
Hospital Hietzing
Other
Assessment of Long-term Intraocular Lens (IOL) Decentration and Tilt in Eyes With Pseudoexfoliation Syndrome (PES) Following Cataract Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06460389
Cataract, Eye Diseases
Alexandroupoli, Evros, Greece
View Trial DetailsNCT02137161
Cataract, Exfoliation Syndrome
Reggio Emilia, RE, Italy
View Trial DetailsNCT06578923
Cataract, Eye Diseases
Nyíregyháza, Hungary
View Trial DetailsNCT06578910
Cataract, Eye Diseases
Szeged, Hungary
View Trial Details